MBXBF
Price
$0.21
Change
-$0.01 (-4.55%)
Updated
Jul 24 closing price
Capitalization
30.07M
MMIRF
Price
$0.05
Change
+$0.04 (+400.00%)
Updated
Jul 22 closing price
Capitalization
38.69M
Interact to see
Advertisement

MBXBF vs MMIRF

Header iconMBXBF vs MMIRF Comparison
Open Charts MBXBF vs MMIRFBanner chart's image
Microbix Biosystems
Price$0.21
Change-$0.01 (-4.55%)
Volume$100K
Capitalization30.07M
Medmira
Price$0.05
Change+$0.04 (+400.00%)
Volume$1.5K
Capitalization38.69M
MBXBF vs MMIRF Comparison Chart in %
Loading...
MBXBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MMIRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MBXBF vs. MMIRF commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MBXBF is a Hold and MMIRF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 26, 2025
Stock price -- (MBXBF: $0.21 vs. MMIRF: $0.05)
Brand notoriety: MBXBF and MMIRF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MBXBF: 438% vs. MMIRF: 18%
Market capitalization -- MBXBF: $30.07M vs. MMIRF: $38.69M
MBXBF [@Biotechnology] is valued at $30.07M. MMIRF’s [@Biotechnology] market capitalization is $38.69M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MBXBF’s FA Score shows that 1 FA rating(s) are green whileMMIRF’s FA Score has 1 green FA rating(s).

  • MBXBF’s FA Score: 1 green, 4 red.
  • MMIRF’s FA Score: 1 green, 4 red.
According to our system of comparison, MMIRF is a better buy in the long-term than MBXBF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MBXBF’s TA Score shows that 3 TA indicator(s) are bullish while MMIRF’s TA Score has 3 bullish TA indicator(s).

  • MBXBF’s TA Score: 3 bullish, 4 bearish.
  • MMIRF’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, both MBXBF and MMIRF are a bad buy in the short-term.

Price Growth

MBXBF (@Biotechnology) experienced а -2.33% price change this week, while MMIRF (@Biotechnology) price change was +257.86% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.58%. For the same industry, the average monthly price growth was +17.35%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

MBXBF is expected to report earnings on May 15, 2025.

MMIRF is expected to report earnings on Jul 01, 2025.

Industries' Descriptions

@Biotechnology (+7.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MMIRF($38.7M) has a higher market cap than MBXBF($30.1M). MMIRF YTD gains are higher at: 282.443 vs. MBXBF (-26.021). MBXBF has higher annual earnings (EBITDA): 4.35M vs. MMIRF (-3.24M). MBXBF has more cash in the bank: 14.5M vs. MMIRF (18.3K). MBXBF has less debt than MMIRF: MBXBF (5.35M) vs MMIRF (10.2M). MBXBF has higher revenues than MMIRF: MBXBF (22.7M) vs MMIRF (254K).
MBXBFMMIRFMBXBF / MMIRF
Capitalization30.1M38.7M78%
EBITDA4.35M-3.24M-134%
Gain YTD-26.021282.443-9%
P/E Ratio26.44N/A-
Revenue22.7M254K8,937%
Total Cash14.5M18.3K79,235%
Total Debt5.35M10.2M52%
FUNDAMENTALS RATINGS
MBXBF vs MMIRF: Fundamental Ratings
MBXBF
MMIRF
OUTLOOK RATING
1..100
2446
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
5
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
82100
PRICE GROWTH RATING
1..100
8436
P/E GROWTH RATING
1..100
8100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MMIRF's Valuation (5) in the null industry is significantly better than the same rating for MBXBF (77). This means that MMIRF’s stock grew significantly faster than MBXBF’s over the last 12 months.

MMIRF's Profit vs Risk Rating (100) in the null industry is in the same range as MBXBF (100). This means that MMIRF’s stock grew similarly to MBXBF’s over the last 12 months.

MBXBF's SMR Rating (82) in the null industry is in the same range as MMIRF (100). This means that MBXBF’s stock grew similarly to MMIRF’s over the last 12 months.

MMIRF's Price Growth Rating (36) in the null industry is somewhat better than the same rating for MBXBF (84). This means that MMIRF’s stock grew somewhat faster than MBXBF’s over the last 12 months.

MBXBF's P/E Growth Rating (8) in the null industry is significantly better than the same rating for MMIRF (100). This means that MBXBF’s stock grew significantly faster than MMIRF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MBXBFMMIRF
RSI
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
64%
MACD
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
52%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
74%
Bullish Trend 2 days ago
57%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
67%
Advances
ODDS (%)
Bullish Trend 10 days ago
65%
N/A
Declines
ODDS (%)
Bearish Trend 12 days ago
70%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
MBXBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MMIRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TOSCF15.11N/A
N/A
Tosoh Corp.
CATWF0.07N/A
N/A
China Tontine Wines Group Ltd.
NZERF0.16N/A
N/A
New Zealand Energy Corp.
PLRRF6.40N/A
N/A
Polar Capital Holdings PLC
DLICY15.94-0.13
-0.81%
Dai-ichi Life Holdings Inc

MBXBF and

Correlation & Price change

A.I.dvisor tells us that MBXBF and CRMD have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MBXBF and CRMD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MBXBF
1D Price
Change %
MBXBF100%
N/A
CRMD - MBXBF
27%
Poorly correlated
-0.09%
TECX - MBXBF
23%
Poorly correlated
+0.18%
BVNKF - MBXBF
21%
Poorly correlated
-2.18%
NBY - MBXBF
20%
Poorly correlated
+3.23%
MMIRF - MBXBF
15%
Poorly correlated
N/A
More

MMIRF and

Correlation & Price change

A.I.dvisor tells us that MMIRF and NWPHF have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MMIRF and NWPHF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MMIRF
1D Price
Change %
MMIRF100%
N/A
NWPHF - MMIRF
30%
Poorly correlated
N/A
TECX - MMIRF
29%
Poorly correlated
+0.18%
AZTR - MMIRF
24%
Poorly correlated
-4.34%
SRPT - MMIRF
22%
Poorly correlated
-7.38%
SAGE - MMIRF
22%
Poorly correlated
+0.46%
More